Central obesity
Conditions
Interventions
Long needle penetration acupuncture:Long needle penetration acupuncture will be used for abdominal acupoints
Placebo shallow acupuncture group:Acupoints will be treated with placebo shallow needling
Sponsors
Shanghai Seventh People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diagnostic criteria: The BMI, waist circumference, and waist hip ratio will be used to diagnose Central obesity in this study. (1) When BMI>25kg/m2, it can be diagnosed as obesity; (2) When the male waist circumference is = 85cm and the female waist circumference is = 80cm; (3) Male waist to hip ratio>0.9 and female waist to hip ratio>0.8 can be classified as Central obesity. When BMI meets the criteria and there is a waist circumference or waist to hip ratio that meets the diagnostic criteria for Central obesity, it can be considered as meeting the inclusion criteria for Central obesity in this study. ? Within the past 3 months, I have not received weight loss treatment from traditional Chinese and Western medicine or a nutritionist. ? Between the ages of 18 and 65; ? Meets the diagnostic criteria for Central obesity; ? Abdominal obesity patients with spleen deficiency and phlegm dampness. ? Understand and agree to participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: ? Due to medication, or due to disturbances in external brain, pituitary, adrenal cortex function, thyroid function, and autonomic nervous system Secondary obesity caused by factors such as adrenal insufficiency, hypothyroidism, and anterior pituitary dysfunction Decreased fertility, female polycystic ovary syndrome, and obesity caused by traumatic brain injury; ? Taking drugs that may affect the trial results (weight), such as liraglutide, smeglutide, and metformin drugs such as guanidine and hormones; ? The Hamilton Depression Scale 17 (HAMD-17) scored>18; ? Severe ulcers, abscesses, skin infections, etc. are present at the acupuncture site; ? Severe heart, brain, lung, liver, and kidney dysfunction, hematopoietic system diseases, or combined with other serious diseases; ? Participate in other clinical medical trials within the past 3 months; ? Pregnant and lactating women; ? Suffering from other serious visual and auditory impairments or mental illnesses that affect communication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Waist to hip ratio(WHR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index, BMI;Body weight;Body fat rate;Visceral fat area, VFA;Skeletal muscle content;Total cholesterol, TC;Triglycerides, TG;High density lipoprotein-cholesterol, HDL-C;Low-density lipoprotein, LDL-C;Fasting plasma glucose, FPG;Fasting insulin, FINS;10-item Kessler Psychological Distress scale, Kessler 10;The impact of weight on quality of life-lite, IWQOL-Lite;The Trait General Food Cravings Questionnaires, FCQT;Traditional Chinese medicine syndrome rating scale ;Waist circumference,WC;Hip circumference, HC;Insulin resistance, Homa-IR; | — |
Countries
China
Contacts
Public ContactHuang Li
Shanghai Seventh People's Hospital
Outcome results
None listed